The first steps towards developing a vaccine against an insidious sexual transmitted infection (STI) have been accomplished by researchers at McMaster University.
Researchers at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster have developed the first widely protective vaccine against chlamydia, a common STI that is mostly asymptomatic but impacts 113 million people around the world each year and can result in infertility.
In a study, recently published in the journal Vaccine, the researchers show that a novel chlamydial antigen known as BD584 is a potential vaccine candidate for the most common species of chlamydia known as Chlamydia trachomatis.
As most C. trachomatis infections are asymptomatic, chlamydia can often go untreated and lead to upper genital tract infections, pelvic inflammatory disease, and infertility. This is why the promise of a vaccine would be extremely beneficial, says David Bulir, co-author of the study.
“Vaccine development efforts in the past three decades have been unproductive and there is no vaccine approved for use in humans,” said Bulir, who just finished his PhD in medical sciences at McMaster.
“Vaccination would be the best way to way to prevent a chlamydia infection, and this study has identified important new antigens which could be used as part of a vaccine to prevent or eliminate the damaging reproductive consequences of untreated infections.”
In the research team’s study, BD584 was able to reduce chlamydial shedding – a symptom of C. trachomatis – by 95 per cent. The antigen also decreased hydrosalpinx, another C. trachomatis symptom which involves fallopian tubes being blocked with serous fluids, by 87.5 per cent.
The results look very promising, said senior author James Mahony, a professor of Pathology and Molecular Medicine for McMaster’s Michael G. DeGroote School of Medicine and a researcher at St. Joseph Healthcare Hamilton’s Research Institute where the work was performed.
Co-author and McMaster PhD student, Steven Liang, explains, “not only is the vaccine effective, it also has the potential to be widely protective against all C. trachomatis strains, including those that cause trachoma.”
Trachoma is an eye infection caused by chlamydia and is the leading cause of preventable blindness affecting millions of people in many resource-poor regions of the world.
“The vaccine would be administered through the nose. This is easy and painless and does not require highly trained health professionals to administer, and that makes it an inexpensive solution for developing nations,” he said.
The next step is more testing for effectiveness against different strains of Chlamydia and in different formulations. The study was funded by the Canadian Institutes for Health Research.
The Latest on: Chlamydia
via Google News
The Latest on: Chlamydia
- Pay-it-forward model increases STD testing among gay men in China on December 20, 2018 at 8:49 am
Credit: Jon Gardiner/UNC Chapel-Hill Chinese gay men who were offered a free screening for gonorrhea and chlamydia and then asked to donate to the testing of another man were 48 percent more ... […]
- Wear the Gown: Condoms, education prevent STDs from spreading on December 20, 2018 at 7:31 am
Chlamydia, gonorrhea, and syphilis are all on the rise in 2018, continuing a four-year trend according to the CDC. Here in Bexar County, HIV rates are going up too. Texas Wears Condoms is working to p... […]
- Earth Science Tech, Inc. (ETST) Orders First Commercial Production Run of Hygee™ Kits on December 19, 2018 at 6:51 am
The Hygee™ self-sampling kit includes a discreet, wearable medical device that enables a woman to anonymously test for STIs such as chlamydia. Testing for this disease is particularly important for pr... […]
- Chlamydia in Throat: What You Need to Know on December 18, 2018 at 4:09 pm
Chlamydia is a sexually transmitted infection (STI) caused by the bacteria Chlamydia trachomatis. This infection can lead to painful health problems if left untreated. Although STIs primarily affect t... […]
- R. Kelly Makes Surprising Legal Move In Chlamydia Case on December 17, 2018 at 5:28 am
R. Kelly has amped up efforts to fight the man who says the performer ruined his marriage by infecting his wife with a grotty disease. Find out how below… A man named Kenny Bryant is suing Kelly ... […]
- High sensitivity, specificity for chlamydia point-of-care test on December 6, 2018 at 10:52 am
(HealthDay)—A point-of-care (POC) polymerase chain reaction test (Atlas io) has high sensitivity and specificity for Chlamydia trachomatis (CT), according to a study published in the November issue of ... […]
- New Chlamydia Test Offers Rapid Results on December 5, 2018 at 6:42 am
WEDNESDAY, Dec. 5, 2018 (HealthDay News) -- A new test for chlamydia can provide results within 30 minutes, potentially speeding up the start of treatment, researchers say. The rapid test for the sexu... […]
- New chlamydia test offers results within 30 minutes on December 5, 2018 at 6:21 am
WEDNESDAY, Dec. 5, 2018 -- A new test for chlamydia can provide results within 30 minutes, potentially speeding up the start of treatment, researchers say. The rapid test for the sexually transmitted ... […]
- New chlamydia test delivers results in about 30 minutes on November 30, 2018 at 10:20 am
Newswise — NIBIB-funded researchers recently validated a rapid STD test that delivered accurate results in about 30 minutes for chlamydia, allowing patients to receive treatment immediately, thereby s... […]
- Russell Crowe Built an Entire Koala Chlamydia Ward to Prank John Oliver on November 28, 2018 at 6:39 am
But even more than that, he loves blowing HBO's money. And he's pulled some elaborate, expensive gags, like filming dog judges to breathe life into Supreme Court transcripts or starting his own prospe... […]
via Bing News